Three Chinese lawyers and advocates, Cheng Yuan, Wu Gejianxiong, and Liu Yongze, who work on employment discrimination and disability justice for people living with HIV and viral hepatitis, have been wrongfully detained in Hunan, China since 22 July 2019. More

Achieving hepatitis C virus (HCV) elimination by 2030 depends on how countries fund prevention, testing, treatment, and care and how they include HCV in efforts for universal health coverage. Investing in elimination requires national programs to provide services for key populations, (...) More

1-3 March 2019, Penang, Malaysia
Positive Malaysian Treatment Access and Advocacy Group (MTAAG+), with partners Treatment Action Group and the Foundation for Innovative New Diagnostics, convened the first advocacy workshop on hepatitis C virus (HCV) diagnostics. The workshop presented the (...) More

13-15 May 2019, Tbilisi, Georgia
The Georgian Harm Reduction Network (GHRN), in partnership with the Foundation for Innovative New Diagnostics (FIND), Treatment Action Group (TAG), and the Georgia Community Advisory Board (GeCAB)—comprised of medical and other healthcare providers and affected (...) More

Of the 71 million people living with chronic hepatitis C, only ≈20% are aware of their status and less than 5% of people living in LMICs have been diagnosed.
We need simpler & cheaper tests to scale up diagnosis! More

This tutorial has been designed to help you as focal points (or mapCrowders) to enter data in the mapCrowd data fields related to a country that you agreed to inform. It will describe all the necessary steps to properly and easily fill in data.
General Tips / Section Epidemiological data / (...) More

Treatment Action Group (TAG) and Médecins du Monde are happy to announce the launch of mapCrowd 2.0! In this latest version, we added new options, this short document explains.
Let’s explore together the new feature of mapCrowd.2
Go to: www.mapcrowd.org You are landing on the public section (...) More